The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Subscribe To Our Newsletter & Stay Updated
